2022 WSPA Virtual FALL CME Meeting 

Psychedelic Medicine in Substance Use Disorders

Thank You for Attending! Registration is now closed.

October 29, 2022 | 8:00 AM - 12:45 PM PT

Psychiatrists are asking about psychedelic medicine. This meeting provides a timely update to attendees and establishes the framework for future discussions with patients. The meeting will focus on filling in background knowledge, ie the state of the science, and on the ethical and clinical conundrums brought forth by the entrance of psychedelics into the mainstream.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American Psychiatric Association (APA) and Washington State Psychiatric Association. The APA is accredited by the ACCME to provide continuing medical education for physicians. The APA designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Principles of Psychedelic-Assisted Psychotherapy
Dr. Dave Rabin, MD, PhD

Psychedelic Treatments in Substance Use Disorder
Nathan B. Sackett, MD, MS

Basic Science and Chemistry of Psychedelic Compounds
Lindsay P. Cameron, PhD (she/her)


Learning Objectives

1) Examine the potential of psychedelic medicine to be an advance in our ability to help patients across diagnoses.

2) Distinguish the use of psychedelic compounds as psychotherapy adjunts and the use of these compounds as the primary treatment (ie medication).

3) Counsel patients re: potential promise of scientific breakthroughs vs the pitfalls of looking for a panacea.

4) Develop strategies for keeping up with advances while not becoming overwhelmed by hype.

Registration Fees

Members | $90 
Non-Members | $135
Resident Members | Complimentary
Resident Non-Members | $30


8:00 AM Welcome 
Thomas Soeprono, MD
WSPA President
8:05 AM Overview of the Conference
Joshua Bess, MD
8:20 AM Psychedelics: Basic Science
Lindsay P. Camerson, PhD (she/her)
9:10 AM Q &A
9:25 AM

Principles of Psychedelic-Assisted Psychotherapy
Dave Rabin, MD, PhD
Neuroscientist, psychiatrist, health tech entrepreneur, inventor

10:15 AM

Q&A with Dr. Rabin

10:30 AM


10:45 AM

Psychedelic Treatments in Substance Use Disorder
Nathan Sackett, MD, MS
Director, Center for Novel Therapeutics in Addiction Psychiatry (University of Washington) 

11:35 AM  Q & A 
11:45 AM

Panel Discussion | Q&A Presenters
Moderated by Joshua Bess, MD

12:30 PM

Thomas Soeprono, MD
WSPA President


Thank You to Our Sponsor



There are some exciting opportunities to sponsor/exhibit for this event. So why get involved? 

The Fall Meeting...

  • Offers an excellent opportunity to generate new leads for business expansion
  • Provides a relaxed atmosphere to build relationships
  • Is in a virtual format that expands accessibility and reaches more people
  • Generates opportunities to enhance relationships with existing clients
  • Delivers a quality return on investment based on consistent feedback from previous exhibitors
  • Exposes your products and services to our members who have buying power